Published on in Vol 22, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/19703, first published
.

Journals
- Hochstatter K, Gustafson Sr D, Landucci G, Pe-Romashko K, Cody O, Maus A, Shah D, Westergaard R. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial. JMIR mHealth and uHealth 2021;9(2):e23080 View
- Reith M, Kortagere S, Wiers C, Sun H, Kurian M, Galli A, Volkow N, Lin Z. The dopamine transporter gene SLC6A3: multidisease risks. Molecular Psychiatry 2022;27(2):1031 View
- Chen Y, Lin Y, Wu M, Kuo J, Wang C. Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis. Viruses 2024;16(1):142 View
- Pinzón-Gómez C, Langlade J, Gantiva C. Systematic review of cognitive and behavioral strategies used in effective harm reduction interventions for people who use cocaine. Journal of Addictive Diseases 2025;43(2):107 View
- Woodward B, Millar K, Carter G. A community‐based participatory research approach to evaluating and improving hepatitis C risk, knowledge, and stigma associations among people who inject substances in Indiana. Public Health Nursing 2024;41(5):961 View
- Ganesh S, Goldshear J, Wilkins P, Kovalsky E, Simpson K, Page C, Corsi K, Ceasar R, Barocas J, Bluthenthal R. Risk Factors for Infective Endocarditis and Serious Injection Related Infections Among People Who Inject Drugs in Los Angeles, CA and Denver, CO. Drug and Alcohol Dependence 2025;269:112588 View
